companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

THALIDOMIDE VICTIMS ASSN

LONDON-Canada

Company Name:
Corporate Name:
THALIDOMIDE VICTIMS ASSN
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 1105 Jalna Blvd #607,LONDON,ON,Canada 
ZIP Code:
Postal Code:
N6E2S9 
Telephone Number: 6135649000 
Fax Number: 5196851518 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
861102 
USA SIC Description:
Associations 
Number of Employees:
1 to 4 
Sales Amount:
 
Credit History:
Credit Report:
Institution 
Contact Person:
Randolph Warren 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
THAMES EMS INC
THAM, P L MD
THAM P L DR PHYS
Next company profile:
THAIFOON RESTAURANT
THAIN DONALD H PROF
THAI TASTE










Company News:
  • Lenalidomide - ALZFORUM
    Lenalidomide is structurally similar to thalidomide, and as such is considered a teratogen with the potential to cause birth defects and fetal death Lenalidomide is being pursued as an alternative to thalidomide, whose development for AD was stopped because of dose-limiting toxicity in elderly patients (Decourt et al , 2017)
  • Therapeutics Search | ALZFORUM
    NSC001 AAB-003 AADvac1 AAV-GAD AAV2-BDNF ABBV-1088 ABBV-552 ABBV-916 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac40 ACD856 Acetyl-l-carnitine HCI ACI-24 060 ACI-3024 ACI-7104 056 Acitretin ACP-204 ADEL-Y01 Aduhelm AF 102B Affitope AD02 AGB101 AIT-101 AKST4290 AL002 AL003 AL044 AL101 ALIA-1758 Allopregnanolone Alpha-Tocopherol ALX-001 ALZ-101
  • Timeline - Small Molecule | ALZFORUM
    Phase 2 NIC5-15 Phase 2 Neflamapimod Phase 2 Nelonicline Phase 2 ORM-12741 Phase 2 PF-05212377 Phase 2 Pioglitazone Phase 2, Phase 3 Piromelatine Phase 2 Relyvrio Phase 2 Riluzole Phase 2 Saracatinib Phase 2 Simufilam Phase 2 Thalidomide Phase 2 3 Umibecestat Phase 2, Phase 2 3 Varoglutamstat Phase 2 Verubecestat Phase 1, Phase 2 3, Phase 3
  • Timeline - Inflammation | ALZFORUM
    Study aborted Inflammation 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 ALZT-OP1 Phase 3 Azeliragon Phase 2 3, Phase 3 CHF 5074 Phase 2 GRF6019 Phase 2 Gamunex Phase 2 3 Neflamapimod Phase 2 Octagam®10% Phase 2 Pioglitazone Phase 2, Phase 3 Sargramostim Phase
  • Getting to First BACE: BACE1 Inhibition Takes a Step Forward
    Because the immunomodulatory drug thalidomide is known to inhibit TNF signaling, Shen and colleagues tested thalidomide’s effects in mice, and confirmed that it reduced Aβ levels and plaque numbers
  • Therapeutics | ALZFORUM
    AD Target Therapy Types The two tables below organize the therapeutics within this database by therapy type and proposed target type The number of therapeutics within each category is indicated according to the highest phase each therapeutic has achieved in U S clinical trials For example, if a given therapeutic is in both Phase 2 and Phase 3 trials, it is included in the Phase 3 total




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer